ÂÜÀòÂÒÂ×

Karthik Radhakrishnan is an experienced finance and executive professional, currently serving as Chief Financial Officer at Monopar Therapeutics Inc. Previously, Karthik held leadership positions as President at both Titania Investments LLC and Titania Partners LLC, and contributed as Interim/Founding Chief Executive Officer at Asylia Therapeutics. Karthik also served as Chief Financial Officer at Medicenna Therapeutics Inc. Karthik Radhakrishnan holds a Master of Science in Environmental Engineering from the University at Buffalo and an education from the University of Michigan - Stephen M. Ross School of Business, completed between 2000 and 2002.